Podcast
Questions and Answers
What is the primary rationale behind the increasing interest in targeting epigenetic alterations for cancer treatment?
What is the primary rationale behind the increasing interest in targeting epigenetic alterations for cancer treatment?
- The high cost-effectiveness of epigenetic drugs.
- The limited success of traditional chemotherapies.
- The reversible nature of epigenetic alterations. (correct)
- The irreversible nature of genetic mutations.
Which of the following best describes the current status of drugs targeting histone acetylation and DNA methylation?
Which of the following best describes the current status of drugs targeting histone acetylation and DNA methylation?
- They are being tested in clinical trials with promising results. (correct)
- They have shown limited efficacy in treating solid tumors.
- They are only in preclinical development stages.
- They have been abandoned due to severe side effects.
For which specific types of cancer have decitabine and azacytidine been approved for clinical use by the FDA and EMA?
For which specific types of cancer have decitabine and azacytidine been approved for clinical use by the FDA and EMA?
- Melanoma.
- Solid tumors like breast and lung cancer.
- Gastrointestinal cancers.
- Haematological malignancies and myelodysplastic syndromes. (correct)
What is the primary mechanism of action of decitabine and azacytidine in treating cancer?
What is the primary mechanism of action of decitabine and azacytidine in treating cancer?
What is the significance of targeting epigenetic pathways in cancer therapy compared to traditional chemotherapy?
What is the significance of targeting epigenetic pathways in cancer therapy compared to traditional chemotherapy?
Flashcards
Epigenetic therapy
Epigenetic therapy
A treatment approach targeting reversible epigenetic changes in cancer.
Histone acetylation
Histone acetylation
The process of adding acetyl groups to histones, impacting gene expression.
DNA methylation
DNA methylation
The addition of methyl groups to DNA, often silencing genes.
Decitabine
Decitabine
Signup and view all the flashcards
Clinical trials
Clinical trials
Signup and view all the flashcards
Study Notes
Epigenetic Therapy in Cancer
- Epigenetic alterations in cancer are reversible, making them a potential target for therapy.
- Drugs targeting histone acetylation and DNA methylation are being developed.
- Clinical trials of these drugs show promising results for epigenetic therapy.
- Decitabine (Dacogen®) and azacytidine (Vidaza®, Azadine®, Onureg®) are approved DNA demethylating agents.
- These drugs are used for haematological malignancies and myelodysplastic syndromes (MDS).
- FDA and EMA have approved their clinical use.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
